SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Transamerica Financial Advisors Inc.

Transamerica Financial Advisors Inc. lowered its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 5,465 shares of the exchange traded fund’s stock after selling 1,532 shares during the period. Transamerica Financial Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $493,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of XBI. Mirae Asset Securities USA Inc. raised its holdings in SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after buying an additional 600,000 shares during the period. Proficio Capital Partners LLC boosted its position in shares of SPDR S&P Biotech ETF by 16,156.1% during the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares during the period. Raymond James Financial Inc. purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $55,529,000. Whittier Trust Co. lifted its stake in SPDR S&P Biotech ETF by 3.1% during the fourth quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock worth $28,885,000 after purchasing an additional 9,713 shares in the last quarter. Finally, J.Safra Asset Management Corp boosted its position in shares of SPDR S&P Biotech ETF by 461.6% during the fourth quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after buying an additional 240,415 shares during the period.

SPDR S&P Biotech ETF Trading Down 1.3 %

XBI stock opened at $84.40 on Friday. The business’s fifty day moving average price is $89.40 and its 200 day moving average price is $93.94. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The company has a market capitalization of $5.47 billion, a PE ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.